Overview This third phase of GAP-f’s strategy (2025-2030) focuses on strengthening the global ecosystem for paediatric medicines. With a streamlined approach and deeper collaboration across sectors, the strategy aims to accelerate the development, approval, and uptake of child-friendly formulations—prioritizing where the need is greatest. Anchored in equity and impact, GAP-f will work with countries, regulators, […]
27 May 2025
Keyword